Dr. Reddy's Generic Found Not To Infringe Lunesta Patent
U.S. District Judge Dennis M. Cavanaugh granted Dr. Reddy’s move for summary judgment of noninfringement as to U.S. Patent No. 6,444,673 over its planned drug, saying that the generic doesn’t fall within the scope of Sunovion’s asserted claims for the '673 patent.
At issue is...
To view the full article, register now.